M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 1.56 USD -1.27% Market Closed
Market Cap: 166.4m USD

Wall Street
Price Targets

MXCT Price Targets Summary
MaxCyte Inc

Wall Street analysts forecast MXCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MXCT is 6.47 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

Lowest
Price Target
5.05 USD
224% Upside
Average
Price Target
6.47 USD
315% Upside
Highest
Price Target
9.45 USD
506% Upside
MaxCyte Inc Competitors:
Price Targets
RVU
Ryvu Therapeutics SA
101% Upside
DHR
Danaher Corp
14% Upside
OABI
OmniAb Inc
302% Upside
TKNO
Alpha Teknova Inc
141% Upside
ANTHEM
Anthem Biosciences Ltd
23% Upside
WAT
Waters Corp
9% Upside
BIO
Bio Rad Laboratories Inc
19% Upside
ERF
Eurofins Scientific SE
5% Upside

Revenue
Forecast

Revenue Estimate
MaxCyte Inc

For the last 11 years the compound annual growth rate for MaxCyte Inc's revenue is 17%. The projected CAGR for the next 4 years is 16%.

17%
Past Growth
16%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
MaxCyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
MaxCyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MXCT's stock price target?
Price Target
6.47 USD

According to Wall Street analysts, the average 1-year price target for MXCT is 6.47 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

What is MaxCyte Inc's Revenue forecast?
Projected CAGR
16%

For the last 11 years the compound annual growth rate for MaxCyte Inc's revenue is 17%. The projected CAGR for the next 4 years is 16%.

Back to Top